4//SEC Filing
Taveras Arthur 4
Accession 0001628280-21-005665
CIK 0001501697other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 5:07 PM ET
Size
5.4 KB
Accession
0001628280-21-005665
Insider Transaction Report
Form 4
Taveras Arthur
Chief Scientific Officer
Transactions
- Award
Common Stock
2021-03-24+8,035→ 8,035 total
Footnotes (2)
- [F1]Grant of restricted stock units to the Reporting Person under the Issuer's Amended and Restated 2017 Equity Incentive Plan with each restricted stock unit representing the right to receive one share of common stock on the applicable vesting date. No amount was paid upon the grant of the restricted stock units. The restricted stock units vest in three equal annual installments on February 11, 2022, February 11, 2023 and February 11, 2024 subject to the Reporting Person continuing to provide service as an employee of the Issuer through such date.
- [F2]Represents unvested restricted stock units.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001830901
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 5:07 PM ET
- Size
- 5.4 KB